Dr. Patrick Cobb, MD
Claim this profileSt. Vincent Frontier Cancer Center
Studies Breast Cancer
Studies Non-Small Cell Lung Cancer
24 reported clinical trials
48 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
BRCA positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
BRAF negative
Affiliated Hospitals
Clinical Trials Patrick Cobb, MD is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting1 award Phase 2 & 320 criteria
More about Patrick Cobb, MD
Clinical Trial Related6 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Patrick Cobb, MD has experience with
- Carboplatin
- Pembrolizumab
- Placebo
- Pemetrexed
- Rituximab
- Atezolizumab
Breakdown of trials Patrick Cobb, MD has run
Breast Cancer
Non-Small Cell Lung Cancer
Lymphoma
Solid Tumors
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Patrick Cobb, MD specialize in?
Is Patrick Cobb, MD currently recruiting for clinical trials?
Are there any treatments that Patrick Cobb, MD has studied deeply?
What is the best way to schedule an appointment with Patrick Cobb, MD?
What is the office address of Patrick Cobb, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.